The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Karrison, Theodore
One or more keywords matched the following items that are connected to Karrison, Theodore
Item TypeName
Concept Survival Analysis
Academic Article Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series.
Academic Article Therapy-related myelodysplastic syndrome: morphologic subclassification may not be clinically relevant.
Academic Article A Phase II trial of suramin monthly x 3 for hormone-refractory prostate carcinoma.
Academic Article Dynamic contrast-enhanced magnetic resonance imaging pharmacodynamic biomarker study of sorafenib in metastatic renal carcinoma.
Academic Article Phase II study of sunitinib malate in head and neck squamous cell carcinoma.
Academic Article Dose-ranging pharmacodynamic study of tipifarnib (R115777) in patients with relapsed and refractory hematologic malignancies.
Academic Article A phase II trial of gemcitabine, capecitabine, and bevacizumab in metastatic renal carcinoma.
Academic Article Use of Irwin's restricted mean as an index for comparing survival in different treatment groups--interpretation and power considerations.
Academic Article Confidence intervals for median survival times under a piecewise exponential model with proportional hazards covariate effects.
Academic Article Comparison of median survival times with adjustment for covariates.
Academic Article The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target.
Academic Article Restricted mean survival time: Does covariate adjustment improve precision in randomized clinical trials?
Academic Article A UGT1A1 genotype-guided dosing study of modified FOLFIRINOX in previously untreated patients with advanced gastrointestinal malignancies.
Academic Article A randomized phase 2 network trial of tivantinib plus cetuximab versus cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma.
Search Criteria
  • Survival Analysis